Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Kinder Morgan Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.06 (market cap $3.94B), while Kinder Morgan Inc trades at $33.37 (market cap $74.44B). The key difference: Kinder Morgan Inc is far larger — about 18.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Kinder Morgan Inc pays a 3.53% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Kinder Morgan Inc for 151 Days on average.
| EWTX | KMI | |
|---|---|---|
Market Cap | $3.94B | $74.44B |
Volume | 810,104 | 10,771,998 |
Sector | Health | Energy |
52-Week High | $48.35 | $34.31 |
52-Week Low | $14.89 | $25.84 |
Typical Hold Time | 0 Days | 151 Days |
Enterprise Value | $3.48B | $106.49B |
Dividend Yield | — | 3.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kinder Morgan (KMI) trades at $33.35, up 0.82% with a bullish technical outlook. The company delivered three consecutive earnings beats in 2026, with Q3 results pending. Revenue grew to $16.94B in 2025, while net income reached $3.06B. Analyst consensus is mixed with a $37.20 price target, representing 11.5% upside. Recent news highlights the company's $6B-$7B growth pipeline and resilience amid energy market volatility.
KMI offers income investors a compelling opportunity with strong cash flows and a visible growth backlog, though elevated debt levels and energy market sensitivity present risks. The stock's current valuation appears reasonable relative to peers, with technical indicators supporting near-term bullish momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
